Real-Time Monitoring of Cisplatin-Induced Cell Death
Author Information
Author(s): Alborzinia Hamed, Can Suzan, Holenya Pavlo, Lederer Catharina, Kitanovic Elke, Wölfl Igor, Scholl Stefan
Primary Institution: Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany
Hypothesis
How does cisplatin trigger cell death over time in a cell population?
Conclusion
Cisplatin treatment leads to a clear timeline of metabolic responses and cell death in different cancer cell lines.
Supporting Evidence
- Cisplatin treatment leads to immediate and delayed metabolic adaptations in cancer cells.
- Cell death in sensitive cell lines starts within 8 to 11 hours of cisplatin treatment.
- Different cancer cell lines show distinct responses to cisplatin treatment.
- MCF-7 cells exhibit a unique metabolic response compared to other cell lines.
- Gene expression changes indicate a transition from stress response to apoptosis.
Takeaway
This study shows how cancer cells react to a drug called cisplatin over time, helping us understand when the cells start to die.
Methodology
The study used a cell biosensor chip system to continuously monitor changes in respiration, glycolysis, and impedance in cancer cell lines treated with cisplatin.
Limitations
The study primarily focused on specific cancer cell lines and may not generalize to all types of cancer.
Participant Demographics
The study involved various cancer cell lines, including MCF-7, MDA-MB-231, HT-29, HCT-116, and HepG2.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website